We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.22B
AUM Growth
+$186M
Cap. Flow
+$231M
Cap. Flow %
10.43%
Top 10 Hldgs %
42.94%
Holding
2,313
New
704
Increased
422
Reduced
406
Closed
646

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$29.3M
2
CPE
Callon Petroleum Company
CPE
+$20.4M
3
MDSO
Medidata Solutions, Inc.
MDSO
+$15M
4
PSDO
Presidio, Inc. Common Stock
PSDO
+$13.9M
5
MSFT icon
Microsoft
MSFT
+$7.53M

Top Sells

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$41.9M
2
RHT
Red Hat Inc
RHT
+$37.8M
3
ARRY
Array Biopharma Inc
ARRY
+$26.1M
4
FDC
First Data Corporation
FDC
+$25.5M
5
BID
Sotheby's
BID
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 6.33%
2 Healthcare 5.48%
3 Consumer Discretionary 4.35%
4 Industrials 3%
5 Real Estate 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOTS
1601
DELISTED
Adesto Technologies Corp
IOTS
$3K ﹤0.01%
+400
New +$3.73K
PGNX
1602
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3K ﹤0.01%
540
-60
-10% -$299
YELL
1603
DELISTED
Yellow Corporation Common Stock
YELL
$3K ﹤0.01%
+1,141
New +$3.59K
DVAX
1604
DELISTED
Dynavax Technologies
DVAX
$2K ﹤0.01%
+486
New +$1.88K
KYNB
1605
Kyntra Bio
KYNB
$29.4M
$2K ﹤0.01%
+2
New +$2.2K
GENC icon
1606
Gencor Industries
GENC
$212M
$2K ﹤0.01%
+200
New +$2.42K
GLNG icon
1607
Golar LNG
GLNG
$5.13B
$2K ﹤0.01%
162
-90
-36% -$1.32K
HOOK
1608
DELISTED
HOOKIPA Pharma
HOOK
$2K ﹤0.01%
+33
New +$2.44K
IMMR icon
1609
Immersion
IMMR
$252M
$2K ﹤0.01%
+231
New +$1.83K
TRN icon
1610
PUT
Trinity Industries
TRN
$2.38B
$2K ﹤0.01%
+100
New +$1.89K
VYGR icon
1611
Voyager Therapeutics
VYGR
$201M
$2K ﹤0.01%
108
-11
-9% -$231
LTRPA
1612
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$2K ﹤0.01%
+200
New +$2.09K
OBSV
1613
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2K ﹤0.01%
259
-824
-76% -$7.86K
XLRN
1614
DELISTED
Acceleron Pharma
XLRN
$2K ﹤0.01%
59
-2
-3% -$87
UROV
1615
DELISTED
Urovant Sciences Ltd.
UROV
$2K ﹤0.01%
166
-134
-45% -$1.16K
FIT
1616
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
$2K ﹤0.01%
+400
New +$1.49K
WMGI
1617
CALL
DELISTED
Wright Medical Group Inc
WMGI
$2K ﹤0.01%
+100
New +$2.38K
LVGO
1618
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$2K ﹤0.01%
+97
New +$2.93K
STML
1619
DELISTED
Stemline Therapeutics, Inc.
STML
$2K ﹤0.01%
216
+155
+254% +$2.03K
TUES
1620
DELISTED
Tuesday Morning Corp
TUES
$2K ﹤0.01%
+1,100
New +$1.72K
ARWR icon
1621
Arrowhead Research
ARWR
$12.4B
$1K ﹤0.01%
+22
New +$651
DLTR icon
1622
Dollar Tree
DLTR
$25.2B
$1K ﹤0.01%
+8
New +$837
FENC icon
1623
Fennec Pharmaceuticals
FENC
$402M
$1K ﹤0.01%
270
-32
-11% -$141
FOLD
1624
CALL
DELISTED
Amicus Therapeutics
FOLD
$1K ﹤0.01%
+100
New +$1.08K
GH icon
1625
Guardant Health
GH
$22.6B
$1K ﹤0.01%
11
-1,389
-99% -$122K
63 64
65
66 67

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Prelude Capital Management held 2,313 positions worth $2.22B, up 9.1% from $2.03B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Prelude Capital Management deployed $231M of net new capital in Q3 2019, opening 704 new positions and adding to 422 existing holdings. Its largest new stake was Callon Petroleum Company: 418,579 shares worth $18.2M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Stewart Information Services, an estimated $7.45M trimmed.

  • Prelude Capital Management's largest Q3 2019 buy was Callon Petroleum Company: 418,579 shares worth $18.2M.
  • Prelude Capital Management added most to Altaba Inc in Q3 2019, an estimated $29.3M increase.
  • Prelude Capital Management's biggest Q3 2019 reduction was Stewart Information Services, cutting an estimated $7.45M.
  • Prelude Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $41.9M.
  • Prelude Capital Management's ten largest holdings make up 43% of its $2.22B portfolio in Q3 2019.
  • Prelude Capital Management opened 704 new positions and closed 646 in Q3 2019.
  • Prelude Capital Management's portfolio value rose 9.1% quarter-over-quarter to $2.22B.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.